|
| 37467079 | The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis. | Rheumatology (Oxford) | 2024 |
| 37707533 | Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium. | Rheumatology (Oxford) | 2024 |
| 36564154 | Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis. | Ann Rheum Dis | 2023 |
| 37698987 | Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry. | Rheumatology (Oxford) | 2023 |
| 37494472 | Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes. | Sci Transl Med | 2023 |
| 37188756 | Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. | Nat Rev Rheumatol | 2023 |
| 36580032 | Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation. | Arthritis Rheumatol | 2023 |
| 36600186 | Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis. | Ann Rheum Dis | 2023 |
| 35094092 | Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis. | Hum Mol Genet | 2022 |
| 35551065 | The Effects of a Web-Based Tool for Parents of Children With Juvenile Idiopathic Arthritis: Randomized Controlled Trial. | J Med Internet Res | 2022 |
| 35486225 | Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis. | Clin Rheumatol | 2022 |
| 36384526 | Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective. | Pediatr Rheumatol Online J | 2022 |
| 35225221 | Juvenile dermatomyositis. Where are we now? | Clin Exp Rheumatol | 2022 |
| 33393715 | The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness. | Arthritis Rheumatol | 2021 |
| 33731872 | Biological classification of childhood arthritis: roadmap to a molecular nomenclature. | Nat Rev Rheumatol | 2021 |
| 33782593 | Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature. | Nat Rev Rheumatol | 2021 |
| 33497020 | Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis. | Arthritis Rheumatol | 2021 |
| 33603671 | Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis. | Front Pharmacol | 2021 |
| 34671713 | Mapping the current psychology provision for children and young people with juvenile dermatomyositis. | Rheumatol Adv Pract | 2021 |
| 34758253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 |
| 34541451 | A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective. | Rheumatol Adv Pract | 2021 |
| 34563217 | JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology. | Pediatr Rheumatol Online J | 2021 |
| 34414384 | Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. | Med | 2021 |
| 34136509 | Similarities and Differences Between Juvenile and Adult Spondyloarthropathies. | Front Med (Lausanne) | 2021 |
| 33146389 | Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models. | Rheumatology (Oxford) | 2021 |
| 30875458 | Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis. | Arthritis Care Res (Hoboken) | 2020 |
| 33298944 | Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. | Nat Commun | 2020 |
| 32845750 | COVID-19 infection in children and adolescents. | Br J Hosp Med (Lond) | 2020 |
| 32213346 | Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. | Cell Metab | 2020 |
| 28589751 | Modelling disease activity in juvenile dermatomyositis: A Bayesian approach. | Stat Methods Med Res | 2019 |
| 31215480 | Being on the juvenile dermatomyositis rollercoaster: a qualitative study. | Pediatr Rheumatol Online J | 2019 |
| 31199482 | An international survey of developing classification criteria for juvenile dermatomyositis-scleroderma overlap. | Rheumatology (Oxford) | 2019 |
| 31331873 | Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions. | Lancet Child Adolesc Health | 2019 |
| 30863750 | Driving Medical Innovation Through Interdisciplinarity: Unique Opportunities and Challenges. | Front Med (Lausanne) | 2019 |
| 30705679 | Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration. | Front Immunol | 2019 |
| 30861625 | Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation. | Arthritis Rheumatol | 2019 |
| 31113443 | Development of a benchmarking toolkit for adolescent and young adult rheumatology services (BeTAR). | Pediatr Rheumatol Online J | 2019 |
| 31138531 | Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. | Ann Rheum Dis | 2019 |
| 30378704 | Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features. | Neuropathol Appl Neurobiol | 2019 |
| 30350355 | Innate Lymphoid Cells and T Cells Contribute to the Interleukin-17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis. | Arthritis Rheumatol | 2019 |
| 29770465 | Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis. | Neuropathol Appl Neurobiol | 2019 |
| 28855174 | The EuroMyositis registry: an international collaborative tool to facilitate myositis research. | Ann Rheum Dis | 2018 |
| 30124602 | Juvenile dermatomyositis: novel treatment approaches and outcomes. | Curr Opin Rheumatol | 2018 |
| 29988398 | CD19<sup>+</sup>CD24<sup>hi</sup>CD38<sup>hi</sup> B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α. | Front Immunol | 2018 |
| 29925386 | The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis. | Pediatr Rheumatol Online J | 2018 |
| 30111380 | Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study. | Arthritis Res Ther | 2018 |
| 30627693 | Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective study. | Rheumatol Adv Pract | 2018 |
| 30619311 | Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools. | Front Immunol | 2018 |
| 29648683 | Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition. | Arthritis Rheumatol | 2018 |
| 29618462 | Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. | Blood Adv | 2018 |